Immutep Limited

As of December 31, 2024, Immutep Limited carries a market capitalization of 324.80M, placing it among publicly traded companies globally. Its enterprise value stands at 227.25M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Immutep Limited's next confirmed earnings release is scheduled for February 25, 2027.

As of December 31, 2024, Immutep Limited has 7.48M shares outstanding.

These figures are as of December 31, 2024.

As of December 31, 2024, Immutep Limited maintains a current ratio of 18.86, meaning it holds 18.9x the short-term assets needed to cover near-term liabilities.

These figures cover the twelve months ended December 31, 2024.

As of the close on October 22, 2026, Immutep Limited's stock has declined approximately 92.07% over the past 52 weeks. The 50-day moving average sits at 5.81, while the 200-day moving average is 18.77.

As of December 31, 2024, Immutep Limited holds 98.59M in cash and equivalents against 1.04M in total debt, resulting in a net debt position of -45.10M. Total book value stands at 106.77M, with working capital of 101.87M providing operational flexibility.

These figures cover the twelve months ended December 31, 2024.

Over the twelve months ended December 31, 2024, Immutep Limited paid dividends of - - per share. Total shareholder yield is negative at -18.14, meaning Immutep Limited raised more capital through share issuance and new debt than it returned via dividends and buybacks.

Immutep Limited's most recent stock split took place on September 28, 2026 with a 20:1 split ratio.